Evidence map›Paper›PMID 38415256›Full record

SynthesisFrontiers in immunology2024

HLH as an additional warning sign of inborn errors of immunity beyond familial-HLH in children: a systematic review.

Silvia Ricci, Walter Maria Sarli, Lorenzo Lodi, Clementina Canessa, Francesca Lippi, Donata Dini, Marta Ferrari, Laura Pisano, Elena Sieni, Giuseppe Indolfi and 2 more

Erratum issuedOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in Frontiers in immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Case report: A cyclic neutropenia patient withFrontiers in immunology · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Silvia Ricci *Department of Health Sciences, University of Florence, Florence, Italy.
Walter Maria Sarli *Department of Health Sciences, University of Florence, Florence, Italy.
Lorenzo LodiDepartment of Health Sciences, University of Florence, Florence, Italy.
Clementina CanessaImmunology Division, Section of Pediatrics, Meyer Childrens Hospital IRCCS, Florence, Italy.
Francesca LippiImmunology Division, Section of Pediatrics, Meyer Childrens Hospital IRCCS, Florence, Italy.
Donata DiniDepartment of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy.
Marta FerrariDepartment of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy.
Laura PisanoDepartment of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy.
Elena SieniPediatric Hematology-Oncology Department, Meyer Children's Hospital IRCCS, Florence, Italy.
Giuseppe IndolfiDepartment of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy.
Massimo RestiDepartment of Pediatrics, Meyer Children's Hospital IRCCS, Florence, Italy.
Chiara AzzariDepartment of Health Sciences, University of Florence, Florence, Italy.
Meyer Children's Hospital · ITUniversity of Florence · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Hemophagocytic Lymphohistiocytosis (HLH) is a rare and life-threatening condition characterized by a severe impairment of the immune homeostasis. While Familial-HLH (FHL) is a known cause, the involvement of other Inborn Errors of Immunity (IEI) in pediatric-HLH remains understudied. Objective: This systematic review aimed to assess the clinical features, triggers, laboratory data, treatment, and outcomes of pediatric HLH patients with IEI other than FHL (IEInotFHL), emphasizing the importance of accurate identification and management. Methods: A systematic search for studies meeting inclusion criteria was conducted in PubMed, EMBASE, MEDLINE, and Cochrane Central. Quality assessment was performed through JBI criteria. Results: A comprehensive search yielded 108 records meeting inclusion criteria, involving 178 patients. We identified 46 different IEI according to IUIS 2022 Classification. Combined immunodeficiencies, immune dysregulation disorders, and phagocyte defects were the IEI most frequently associated with HLH. In 75% of cases, HLH preceded the IEI diagnosis, often with an unrecognized history of severe infections. Triggers reflected the specific infection susceptibilities within IEI groups. Liver and central nervous system involvement were less common than in FHL cases. Treatment approaches and outcomes varied, with limited long-term follow-up data, limiting the assessment of therapeutic efficacy across IEI groups. Conclusion: A comprehensive evaluation encompassing immunological, infectious, and genetic aspects is essential in pediatric-HLH. Relying solely on FHL or EBV susceptibility disorders tests is insufficient, as diverse other IEI can contribute to HLH. Early recognition of HLH as a potential warning sign can guide timely diagnostic investigations and facilitate tailored therapeutic interventions for improved outcomes. Systematic review registration: https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=371425, PROSPERO, CRD42022371425.

Indexed as

Immune System DiseasesLymphohistiocytosis, HemophagocyticChildDisease SusceptibilityHomeostasisHumansfamilial hemophagocytic lymphohistiocytosishemophagocytic lymphohistiocytosishemophagocytic syndromeimmune deficiencyinborn errors of immunitymacrophage activation syndrome

Identifiers

PMID38415256
PMCPMC10896843
OpenAlexW4391783749

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.